Sangamo Therapeutics (SGMOQ) FCF Margin (2010 - 2025)
Sangamo Therapeutics' FCF Margin came in at -171.61% for Q4 2025, down 125.22 percentage points from -46.39% a year earlier but up 4744.39 percentage points from the prior quarter.
Sangamo Therapeutics (SGMOQ) FCF Margin (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' FCF Margin was -246.03%, down 129.41 percentage points from FY2024.
- FCF Margin carries a five-year change of -377.31 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -116.62% in FY2024 (+22.97 pp), -139.59% in FY2023 (+79.46 pp), -219.05% in FY2022 (+12.68 pp) and -231.73% in FY2021 (-363.01 pp).
- The five-year range for quarterly FCF Margin is -10117.05% (Q1 2024) to 23.57% (Q3 2024).
- Year-over-year, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of -179.65 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2025 (a gain of 9710.82 percentage points), and the weakest in Q1 2024 (a drop of 10068.62 percentage points).
- Business Quant data shows SGMOQ's FCF Margin at -4916.01% (Q3 2025), -99.19% (Q2 2025) and -406.23% (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Sangamo Therapeutics | 39.23 Mn | -74.88 Mn | - | -171.61% |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -171.61% |
| Sep 30, 2025 | -4,916.01% |
| Jun 30, 2025 | -99.19% |
| Mar 31, 2025 | -406.23% |
| Dec 31, 2024 | -46.39% |
| Sep 30, 2024 | 23.57% |
| Jun 30, 2024 | -7,551.69% |
| Mar 31, 2024 | -10,117.05% |
| Dec 31, 2023 | -2,605.73% |
| Sep 30, 2023 | -532.42% |
| Jun 30, 2023 | -969.29% |
| Mar 31, 2023 | -48.43% |
| Dec 31, 2022 | -236.96% |
| Sep 30, 2022 | -219.32% |
| Jun 30, 2022 | -202.29% |
| Mar 31, 2022 | -218.96% |
| Dec 31, 2021 | -198.57% |
| Sep 30, 2021 | -226.26% |
| Jun 30, 2021 | -214.66% |
| Mar 31, 2021 | -291.10% |
Sangamo Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();